Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001641172-25-022896
Filing Date
2025-08-11
Accepted
2025-08-11 07:11:08
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-08-11

Document Format Files

Seq Description Document Type Size
1 formars.pdf ARS 1778418
  Complete submission text file 0001641172-25-022896.txt   2450951
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39318 | Film No.: 251200142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)